Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brain
Open Access
- 23 September 2010
- journal article
- Published by Springer Science and Business Media LLC in BMC Neuroscience
- Vol. 11 (1), 121
- https://doi.org/10.1186/1471-2202-11-121
Abstract
Background: Sporadic late-onset Alzheimer's disease (AD) appears to evolve from an interplay between genetic and environmental factors. One environmental factor that continues to be of great interest is that of Chlamydia pneumoniae infection and its association with late-onset disease. Detection of this organism in clinical and autopsy samples has proved challenging using a variety of molecular and histological techniques. Our current investigation utilized immunohistochemistry with a battery of commercially available anti-C. pneumoniae antibodies to determine whether C. pneumoniae was present in areas typically associated with AD neuropathology from 5 AD and 5 non-AD control brains. Results: Immunoreactivity for C. pneumoniae antigens was observed both intracellularly in neurons, neuroglia, endothelial cells, and peri-endothelial cells, and extracellularly in the frontal and temporal cortices of the AD brain with multiple C. pneumoniae-specific antibodies. This immunoreactivity was seen in regions of amyloid deposition as revealed by immunolabeling with two different anti-beta amyloid antibodies. Thioflavin S staining, overlaid with C. pneumoniae immunolabeling, demonstrated no direct co-localization of the organism and amyloid plaques. Further, the specificity of C. pneumoniae labeling of AD brain sections was demonstrated using C. pneumoniae antibodies pre-absorbed against amyloid β 1-40 and 1-42 peptides. Conclusions: Anti-C. pneumoniae antibodies, obtained commercially, identified both typical intracellular and atypical extracellular C. pneumoniae antigens in frontal and temporal cortices of the AD brain. C. pneumoniae, amyloid deposits, and neurofibrillary tangles were present in the same regions of the brain in apposition to one another. Although additional studies are required to conclusively characterize the nature of Chlamydial immunoreactivity in the AD brain, these results further implicate C. pneumoniae infection with the pathogenesis of Alzheimer's disease.Keywords
This publication has 47 references indexed in Scilit:
- The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial PeptidePLOS ONE, 2010
- Mechanism of amyloid plaque formation suggests an intracellular basis of Aβ pathogenicityProceedings of the National Academy of Sciences of the United States of America, 2010
- Initial characterization of Chlamydophila (Chlamydia) pneumoniae cultured from the late-onset Alzheimer brainInternational Journal of Medical Microbiology, 2009
- Uptake and intra-inclusion accumulation of exogenous immunoglobulin by Chlamydia-infected cellsBMC Microbiology, 2008
- Inhibition of apoptosis in neuronal cells infected with Chlamydophila (Chlamydia) pneumoniaeBMC Neuroscience, 2008
- Mechanisms of host cell exit by the intracellular bacteriumChlamydiaProceedings of the National Academy of Sciences of the United States of America, 2007
- Senile plaques in Alzheimer’s diseased brains: Possible association of β-amyloid with herpes simplex virus type 1 (HSV-1) L-particlesMedical Hypotheses, 2006
- Detection of Chlamydial Bodies and Antigens in the Central Nervous System of Patients with Multiple SclerosisThe Journal of Infectious Diseases, 2005
- Age Alterations in Extent and Severity of Experimental Intranasal Infection withChlamydophila pneumoniaein BALB/c MiceInfection and Immunity, 2005
- Physiological Roles of Amyloid-?? and Implications for its Removal in Alzheimer???s DiseaseDrugs & Aging, 2004